Literature DB >> 34985721

MiR-20b-5p contributes to the dysfunction of vascular smooth muscle cells by targeting MAGI3 in hypertension.

Minzhi Xu1, Ting Yu2.   

Abstract

INTRODUCTION: MicroRNAs (miRNAs), have been frequently reported to regulate various diseases including hypertension. However, the biological role and regulatory mechanism of miR-20b-5p are unclear in hypertension. The current study aimed to investigate the role of miR-20b-5p in hypertension.
METHODS: Bioinformatics analysis (starBase: http://starbase.sysu.edu.cn ) and a wide range of experiments including blood pressure detection, morphometric sampling by electron microscopy, real-time quantitative polymerase chain reaction (RT-qPCR), CCK-8, western blot, luciferase reporter, hematoxylin and eosin (H&E) staining and Masson trichrome staining assays were used to explore the function and mechanism of miR-20b-5p in hypertension.
RESULTS: MiR-20b-5p level was significantly upregulated in Spontaneously hypertensive rats' (SHRs') thoracic aortic vascular tissues. In function, miR-20b-5p silencing inhibited the proliferation and migration of aortic smooth muscle cells (ASMCs) of SHRs. In mechanism, we predicted 10 potential target mRNAs for miR-20b-5p. After prediction by bioinformatics, MAGI3 was validated to bind with miR-20b-5p. Rescue assays showed that MAGI3 silencing reversed the inhibitive influence of miR-20b-5p depletion on cell proliferation and migration.
CONCLUSIONS: MiR-20b-5p contributed to the dysfunction of ASMCs by targeting MAGI3 in hypertension. This new discovery provided a potential novel insight for hypertension treatment.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  ASMCs; Hypertension; MAGI3; miR-20b-5p

Mesh:

Substances:

Year:  2022        PMID: 34985721     DOI: 10.1007/s10735-021-10050-w

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  31 in total

Review 1.  Regulation of mRNA translation and stability by microRNAs.

Authors:  Marc Robert Fabian; Nahum Sonenberg; Witold Filipowicz
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

2.  Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Lenka Dvorakova; Ladislav Krofta
Journal:  Int J Cardiol       Date:  2019-05-21       Impact factor: 4.164

Review 3.  Protection of cardiac cell-to-cell coupling attenuate myocardial remodeling and proarrhythmia induced by hypertension.

Authors:  T Egan Benova; B Szeiffova Bacova; C Viczenczova; E Diez; M Barancik; N Tribulova
Journal:  Physiol Res       Date:  2016-09-19       Impact factor: 1.881

Review 4.  Hypertension and vascular disease.

Authors:  A E Doyle
Journal:  Am J Hypertens       Date:  1991-02       Impact factor: 2.689

Review 5.  MicroRNAs: history, biogenesis, and their evolving role in animal development and disease.

Authors:  M Bhaskaran; M Mohan
Journal:  Vet Pathol       Date:  2013-09-17       Impact factor: 2.221

Review 6.  Systemic hypertension.

Authors:  William J Elliott
Journal:  Curr Probl Cardiol       Date:  2007-04       Impact factor: 5.200

Review 7.  Resistant Hypertension.

Authors:  Adrian Doroszko; Agnieszka Janus; Ewa Szahidewicz-Krupska; Grzegorz Mazur; Arkadiusz Derkacz
Journal:  Adv Clin Exp Med       Date:  2016 Jan-Feb       Impact factor: 1.727

Review 8.  [Treatment of hypertension in the aged].

Authors:  E Fritschka; A Distler
Journal:  Fortschr Med       Date:  1989-10-30

Review 9.  Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development.

Authors:  Hiroyuki Hao; Giulio Gabbiani; Marie-Luce Bochaton-Piallat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-08-07       Impact factor: 8.311

10.  Association Analysis in Children Born from Normal and Complicated Pregnancies-Cardiovascular Disease Associated microRNAs and the Incidence of Prehypertension/Hypertension, Overweight/Obesity, Valve Problems and Heart Defects.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Ladislav Krofta; Jan Sirc
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.